Classification
Compound class	Synthetic organic

IUPAC Name

3-(3-chloro-4-methylphenyl)-1-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]urea

Comments

Structural studies have shown that thalidomide class immunomodulatory drugs bind in a shallow hydrophobic pocket on the surface of cereblon, that is mediated by a glutarimide ring of the ligand. Binding of small molecules to cereblon can alter its substrate specificity [1]. Thalidomide and its related drugs enhance recruitment of Ikaros and Aiolos to the E3 ubiquitin ligase complex. CC-885 has a different mechanism of action compared to thalidomide, lenalidomide and pomalidomide. The anti-tumour activity of CC-885 is mediated through the cereblon-dependent ubiquitination and degradation of the translation termination factor GSPT1. Patient-derived acute myeloid leukaemia tumour cells exhibit high sensitivity to CC-885, indicating the clinical potential of this mechanism [2].

Database Links
GtoPdb PubChem SID	340590211
PubChem CID	24788636
Search Google for chemical match using the InChIKey	DOEVCIHTTTYVCC-UHFFFAOYSA-N
Search Google for chemicals with the same backbone	DOEVCIHTTTYVCC
Search UniChem for chemical match using the InChIKey	DOEVCIHTTTYVCC-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone	DOEVCIHTTTYVCC